| Literature DB >> 26526106 |
Michael G Daniel1, Carlos-Filipe Pereira2, Ihor R Lemischka3, Kateri A Moore4.
Abstract
Previous attempts to either generate or expand hematopoietic stem cells (HSCs) in vitro have involved either ex vivo expansion of pre-existing patient or donor HSCs or de novo generation from pluripotent stem cells (PSCs), comprising both embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). iPSCs alleviated ESC ethical issues but attempts to generate functional mature hematopoietic stem and progenitor cells (HSPCs) have been largely unsuccessful. New efforts focus on directly reprogramming somatic cells into definitive HSCs and HSPCs. To meet clinical needs and to advance drug discovery and stem cell therapy, alternative approaches are necessary. In this review, we synthesize the strategies used and the key findings made in recent years by those trying to make an HSC. Published by Elsevier Ltd.Entities:
Keywords: hematopoiesis; hematopoietic stem cell; reprogramming; transcription factors
Mesh:
Year: 2015 PMID: 26526106 PMCID: PMC4764442 DOI: 10.1016/j.tcb.2015.10.002
Source DB: PubMed Journal: Trends Cell Biol ISSN: 0962-8924 Impact factor: 20.808